$QSI

4 theses

bullish 100%neutral 0%bearish 0%

Avg return (1w)

-6.7%

Win rate (1w)

33% (3 resolved)

1d 3d 1w 1m 3m 6m 1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Oct 29, 4:01 PM ET

$QSIr/pennystocksDDbullish

u/Emotional-Breath-838 · 5d ago3 prior · awaiting results

Three proteomics biotech penny stocks: NAUT, QSI and PACB

Quantum-Si's Proteus platform offers superior sequencing scale and accuracy with a shift toward high-value non-human markets. Despite profitability challenges and launch delays, the company is well-positioned in the nascent protein sequencing market that is paralleling genomics' growth trajectory.

At post $1.46Now $1.75+19.9% since postedas of Oct 29, 4:01 PM ET

1d—

3d+17.8%

1w—

1m—

3m—

6m—

1y—

original post →

$QSIr/pennystocksDDbullish

u/Leather_Disaster8571 · 124d agono track record yet

Long QSI

BFLY Was the First Act. QSI Is Next.

Quantum-Si's Proteus platform is replicating Jonathan Rothberg's successful playbook of moving expensive, centralized medical devices onto semiconductor platforms. Recent technical progress (17 amino acids detected, automated end-to-end sequencing) signals risk has shifted from 'can this work' to 'when will recognizer engineering complete', while strong cash positioning ($190.4M) enables reach to commercial launch in late 2026 without dilution.

At post $0.89Now $1.75+96.8% since postedas of Oct 29, 4:01 PM ET

1d—

3d+3.9%

1w+4.6%

1m-14.4%

3m-6.2%

6m—

1y—

original post →

$QSIr/pennystocksBullishbullish

u/nifai · 221d agono track record yet

$QSI BIGGEST CATALYST IN ITS ENTIRE HISTORY IS THIS YEAR 2026 AND IT IS INCREDIBLY UNDERVALUED at 0.88. A full overview of its insane flagship technology "Proteus" and recent expectations.

Quantum-Si is positioned to deliver a major platform shift in proteomics through its Proteus system launch in 2026, with multiple near-term catalysts including amino acid detection milestones and growing publication validation. The stock is significantly undervalued at $0.88 given the $30B+ proteomics market opportunity, insider buying, and strong cash runway that mirrors Illumina's early trajectory in genomics.

At post $0.90Now $1.75+94.9% since postedas of Oct 29, 4:01 PM ET

1d-5.2%

3d-9.9%

1w-17.8%

1m+18.0%

3m+11.2%

6m-17.0%

1y—

original post →

$QSIr/pennystocksStock Infobullish

u/Internal-Ad-5333 · 266d ago1 prior · 0% at 3mo

Long QSI

$QSI is literally $1 while Stanford and the U.S. Navy just published papers on its technology yesterday. Market didn’t even catch this lol.

Quantum-Si's benchtop protein sequencing technology is being validated by peer-reviewed research and government labs (Stanford, U.S. Navy) while the stock trades at ~$1 due to macro sentiment. The Proteus platform launches Q3 2026 with expanded throughput; combined with clinical and biodefense validation, the market appears to be underpricing the tech's potential.

At post $1.07Now $1.75+64.3% since postedas of Oct 29, 4:01 PM ET

1d—

3d+0.5%

1w-6.9%

1m-19.1%

3m-7.9%

6m-28.9%

1y—

original post →

End of results.